Navigation Links
Fat-Fighting Chemical Holds Promise
Date:8/27/2009

But research on 'fatostatin' is still in early stages

THURSDAY, Aug. 27 (HealthDay News) -- Researchers report that a manmade chemical appears to have the power to turn off fat production, potentially turning it into a weapon against obesity.

Fat mice injected with the chemical, known as fatostatin, didn't get fatter and developed lower cholesterol and blood sugar levels, the research team said.

But don't run out and ask your doctor for a fatostatin shot quite yet. While the chemical holds promise as a "starting point" to develop new drugs, it's not a drug itself, said study co-author Motonari Uesugi, a researcher at Kyoto University in Japan.

Still, there's the matter of those mice who didn't put on extra ounces. "When fatostatin is injected, mice did not get fat even when they ate a lot," Uesugi said. Furthermore, "we did not see any obvious side effects or toxic effects," he added.

Researchers have long been trying to find a pill to help people fight obesity. Anti-obesity drugs do exist, but they have side effects that convince some patients to stop using them.

Uesugi said his laboratory has samples of 30,000 chemicals and is testing them on human and mouse cells. The molecule in question, fatostatin, appeared to stop fat production by turning certain genetic switches.

In the new study, published in the Aug. 28 issue of the journal Chemistry and Biology, the researchers report that the chemical prevented obese mice from getting fatter even when they could eat whatever they wanted.

But Uesugi said injection of a drug isn't a good option for people with chronic metabolic diseases, such as those that cause obesity. More research needs to be done to develop a drug that could be taken by mouth and is safe for people, he said.

In regards to safety, fatostatin's "activity on 63 genes, many of which have nothing to do with fat synthesis, raises questions about potential side effects, particularly if the chemical is ingested over many years," noted Dr. Nicholas H.E. Mezitis, assistant professor of clinical medicine at Columbia University College of Physicians and Surgeons, who is familiar with the study findings.

For the moment, it is "still challenging" to develop drugs that safely treat obesity, said metabolism researcher Dr. Tae-Hwa Chun, who also is familiar with the report.

A positive finding "in cells and rodents does not always lead to the development of safe and effective drugs for patients," added Chun, an assistant professor at the University of Michigan who specializes in metabolic syndrome.

Still, Chun said, there's promise in the idea of targeting genetic switches that turn on fat production, as fatostatin appears to do.

More information

Learn more about obesity from the National Institutes of Health.



SOURCES: Motonari Uesugi, Ph.D., researcher, Kyoto University, Japan; Tae-Hwa Chun, M.D., Ph.D., assistant professor, University of Michigan, Ann Arbor; Nicholas H.E. Mezitis, M.D., assistant professor of clinical medicine, Columbia University College of Physicians and Surgeons, New York City; Aug. 28, 2009, Chemistry and Biology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chemical culprit in popcorn workers lung identified
2. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
3. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
4. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
5. Low Doses of Red Wine Chemical May Fight Diabetes
6. National Academies advisory: genes and toxic chemicals
7. Genomic technologies to identify toxic chemicals should be developed
8. Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
9. American Chemical Societys Weekly Presspac -- Oct. 17, 2007
10. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
11. Brains Reward Chemical May Help Spur Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fat-Fighting Chemical Holds Promise
(Date:1/16/2017)... ... January 16, 2017 , ... Houston ... Center, is currently offering complimentary consultations and financing for orthodontics for a limited ... bite irregularities and learn about their orthodontic options. Walk-in, late-evening, Saturday, and same-day ...
(Date:1/16/2017)... MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the ... , This year’s influenza shot seems to be having no effect on keeping ... at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... ... , ... San Francisco dentist, Dr. Ben Amini , the founder at ... is capable of taking digital impressions of teeth and gums. Conventional bite impressions have ... restorations , in terms of speed, efficiency and patient comfort. Increasingly, digital impressions are ...
(Date:1/15/2017)... ... 15, 2017 , ... Whole Health Supply, LLC is announcing the release of an updated version ... for purchase. , The 2017 edition has wide jaws that will accommodate nails up ... as well as diabetics. This handle is reinforced for extra strength when pressing down on ...
(Date:1/15/2017)... ... January 15, 2017 , ... The Gravity Vault Indoor Rock Climbing Gym is ... wraps up on the 14,000+ square foot climbing gym, the owners anticipate to open ... in New Jersey and two in New York. With this being its first location ...
Breaking Medicine News(10 mins):
(Date:1/14/2017)... , Jan. 14, 2017  Johnson & Weaver, LLP ... of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... through October 31, 2016 (the "Class Period"). Zimmer ... and markets orthopaedic reconstructive products, such as knee and hip ... ...
(Date:1/13/2017)... Eli Lilly and Company (NYSE: ... ) announced today that the U.S. Food and Drug ... new drug application (NDA) for investigational baricitinib, a once-daily ... rheumatoid arthritis (RA). The NDA for baricitinib was submitted ... FDA extended the action date to allow time to ...
(Date:1/13/2017)... New York , January 13, 2017 ... rising prevalence of AIDS will collectively contribute to the demand ... expected to reach a value of US$ 551.0 Mn by ... will remain the most lucrative markets for western blotting, ... lead the market globally. ...
Breaking Medicine Technology: